| Income Statement | 2025-08-31 | 2024-11-30 | 2024-08-31 | |
|---|---|---|---|---|
| Revenues | 24,200 | 74,248 | 178,887 | |
| Cost of revenues | 8,143 | 7,803 | 8,362 | |
| Gross profit | 16,057 | 66,445 | 170,525 | |
| General and administrative | 23,308 | 40,128 | 61,296 | |
| Contract labor | 42,520 | 54,296 | 45,873 | |
| Professional fees | 7,741 | 7,112 | 36,570 | |
| Officer compensation | 6,000 | 6,000 | 6,000 | |
| Share-based compensation | 0 | - | 100,000 | |
| Rent and lease | 11,059 | 18,439 | 18,248 | |
| Travel | 213 | 97 | 142 | |
| Total operating expenses | 90,841 | 126,072 | 268,129 | |
| Loss from operations | -74,784 | -59,627 | -97,604 | |
| Amortization of discount | 19,815 | - | - | |
| Forgiveness of debt | 0 | - | 23,638 | |
| Change in value of derivative liabilities | 29,322 | - | - | |
| Interest | 17,368 | 8,701 | 2,339 | |
| Other nonoperating expense | - | 11,200 | - | |
| Total other income (expense) | -7,861 | -19,901 | 21,299 | |
| Net loss | -82,645 | -79,528 | -76,305 | |
| Average common stock outstanding, basic | 11,626,749,347 | 10,497,459,730 | 10,458,923,260 | |
| Average common stock outstanding, diluted | 11,626,749,347 | 10,497,459,730 | 10,458,923,260 | |
| Average earnings (loss) per share, basic | -0 | -0 | -0 | |
| Average earnings (loss) per share, diluted | -0 | -0 | -0 | |
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)